Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.3100
-0.0150 (-4.62%)
Aug 21, 2026, 4:10 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 186.12 million as of August 21, 2026. Its market cap has decreased by -34.02% in one year.
Market Cap
186.12M
Enterprise Value
147.67M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
ChartMarket Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 186.12M, an increase of 1,306.15%. That is a compound annual growth rate of 26.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 186.12M | -43.64% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 341.09M |
| Tetratherix | 320.45M |
| Orthocell | 216.44M |
| BLS Pharmaceuticals | 213.88M |
| Nyrada | 177.76M |
| Actinogen Medical | 160.95M |
| Island Pharmaceuticals | 134.64M |
| Recce Pharmaceuticals | 113.80M |